Zentrum fuer klinische Forschung Dr. I. Schoell GmbH
- Address
- Lindenallee 3, Dornholzhausen, 61350 Bad Homburg, Germany
Zentrum für klinische Forschung Dr. I. Schoell GmbH - Center for Clinical Research
Zentrum für klinische Forschung Dr. I. Schoell GmbH is a specialized clinical research center with extensive expertise in neurological and psychiatric disorders. The center demonstrates particular proficiency in conducting Phase 2-4 clinical trials across a diverse range of therapeutic areas, with a strong emphasis on innovative treatment approaches for complex neurological conditions and mental health disorders.
- Neurodegenerative diseases including Alzheimer's Disease, Parkinson's Disease, and Multiple Sclerosis
- Psychiatric conditions such as Major Depressive Disorder, Schizophrenia, and ADHD
- Neurological pain syndromes including migraine headaches and chronic non-specific low back pain
- Rare neurological conditions such as Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
The research center has established capabilities in evaluating novel therapeutic agents, including biologics, small molecules, and biosimilar products. Their research portfolio encompasses dose-response studies, long-term safety evaluations, and comparative effectiveness trials. The center's experience extends to both adult and pediatric populations, demonstrating versatility in managing complex study designs and contributing to the advancement of therapeutic options for patients with treatment-resistant or inadequately controlled neurological and psychiatric conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Zentrum fuer klinische Forschung Dr. I. Schoell GmbH
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A multicenter randomized, double-blind, placebo-controlled Phase 2 study to evaluate efficacy, safety, tolerability, pharmacokinetics and target engagement of GSK3858279 in adult participants with chronic Diabetic Peripheral Neuropathic Pain (DPNP) / NEPTUNE-17. | Glaxosmithkline Research & Development Limited | Phase II | Not Recruiting | Dec 2023 | Oct 2024 |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Gsk3858279 | 1 | Unknown | 2023-12-14 | 2023-12-14 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.